Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Usi...

por Polito, Letizia, Shim, Jinjoo, Hurvitz, Sara A., Dang, Chau T., Knott, Adam, Du Toit, Yolande, Restuccia, Eleonora, Sanglier, Thibaut, Swain, Sandra M.
Publicado 2023

Evaluating the Time Toxicity of Cancer Treatment in the CCTG CO.17 Trial

por Gupta, Arjun, O'Callaghan, Christopher J., Zhu, Liting, Jonker, Derek J., Wong, Ralph P.W., Colwell, Bruce, Moore, Malcolm J., Karapetis, Christos S., Tebbutt, Niall C., Shapiro, Jeremy D., Tu, Dongsheng, Booth, Christopher M.
Publicado 2023

Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study

por Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U., Kater, Arnon P.
Publicado 2023

Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study

por Sheikh, Mahdi, Mukeriya, Anush, Zahed, Hana, Feng, Xiaoshuang, Robbins, Hilary A., Shangina, Oxana, Matveev, Vsevolod, Brennan, Paul, Zaridze, David
Publicado 2023

Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer

por Sánchez-Magraner, Lissete, Gumuzio, Juan, Miles, James, Quimi, Nicole, Martínez del Prado, Purificación, Abad-Villar, María Teresa, Pikabea, Fernando, Ortega, Laura, Etxezarraga, Carmen, Martín-Algarra, Salvador, Lozano, María D., Saiz-Camin, Mónica, Egurrola-Izquierdo, Mikel, Barredo-Santamaría, Inmaculada, Saiz-López, Alberto, Gomez-Mediavilla, Jenifer, Segues-Merino, Nerea, Juaristi-Abaunz, María Aranzazu, Urruticoechea, Ander, Geraedts, Erica J., van Elst, Kim, Claessens, Niels J.M., Italiano, Antoine, Applebee, Christopher J., del Castillo, Sandra, Evans, Charles, Aguirre, Fernando, Parker, Peter J., Calleja, Véronique
Publicado 2023

Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer

por Eriksson, Mikael, Czene, Kamila, Vachon, Celine, Conant, Emily F., Hall, Per
Publicado 2023

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

por Sauta, Elisabetta, Robin, Marie, Bersanelli, Matteo, Travaglino, Erica, Meggendorfer, Manja, Zhao, Lin-Pierre, Caballero Berrocal, Juan Carlos, Sala, Claudia, Maggioni, Giulia, Bernardi, Massimo, Di Grazia, Carmen, Vago, Luca, Rivoli, Giulia, Borin, Lorenza, D'Amico, Saverio, Tentori, Cristina Astrid, Ubezio, Marta, Campagna, Alessia, Russo, Antonio, Mannina, Daniele, Lanino, Luca, Chiusolo, Patrizia, Giaccone, Luisa, Voso, Maria Teresa, Riva, Marta, Oliva, Esther Natalie, Zampini, Matteo, Riva, Elena, Nibourel, Olivier, Bicchieri, Marilena, Bolli, Niccolo’, Rambaldi, Alessandro, Passamonti, Francesco, Savevski, Victor, Santoro, Armando, Germing, Ulrich, Kordasti, Shahram, Santini, Valeria, Diez-Campelo, Maria, Sanz, Guillermo, Sole, Francesc, Kern, Wolfgang, Platzbecker, Uwe, Ades, Lionel, Fenaux, Pierre, Haferlach, Torsten, Castellani, Gastone, Della Porta, Matteo Giovanni
Publicado 2023

High-Grade Serous Carcinoma at Risk-Reducing Salpingo-Oophorectomy in Asymptomatic Carriers of BRCA1/2 Pathogenic Variants: Prevalence and Clinical Factors

por Stroot, Iris A.S., Brouwer, Jan, Bart, Joost, Hollema, Harry, Stommel-Jenner, Denise J., Wagner, Marise M., van Doorn, Helena C., de Hullu, Joanne A., Gaarenstroom, Katja N., Beurden, Marc, van Lonkhuijzen, Luc R.C.W., Slangen, Brigitte F.M., Zweemer, Ronald P., Gómez Garcia, Encarna B., Ausems, Margreet G.E.M., Boere, Ingrid A., van Engelen, Klaartje, van Asperen, Christi J., Schmidt, Marjanka K., Wevers, Marijke R., de Bock, Geertruida H., Mourits, Marian J.E.
Publicado 2023

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

por Dy, Grace K., Govindan, Ramaswamy, Velcheti, Vamsidhar, Falchook, Gerald S., Italiano, Antoine, Wolf, Jürgen, Sacher, Adrian G., Takahashi, Toshiaki, Ramalingam, Suresh S., Dooms, Christophe, Kim, Dong-Wan, Addeo, Alfredo, Desai, Jayesh, Schuler, Martin, Tomasini, Pascale, Hong, David S., Lito, Piro, Tran, Qui, Jones, Simon, Anderson, Abraham, Hindoyan, Antreas, Snyder, Wendy, Skoulidis, Ferdinandos, Li, Bob T.
Publicado 2023

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia: A Study by the International Be...

por van Weelderen, Romy E., Klein, Kim, Harrison, Christine J., Jiang, Yilin, Abrahamsson, Jonas, Arad-Cohen, Nira, Bart-Delabesse, Emmanuelle, Buldini, Barbara, De Moerloose, Barbara, Dworzak, Michael N., Elitzur, Sarah, Fernández Navarro, José M., Gerbing, Robert B., Goemans, Bianca F., de Groot-Kruseman, Hester A., Guest, Erin, Ha, Shau-Yin, Hasle, Henrik, Kelaidi, Charikleia, Lapillonne, Hélène, Leverger, Guy, Locatelli, Franco, Masetti, Riccardo, Miyamura, Takako, Norén-Nyström, Ulrika, Polychronopoulou, Sophia, Rasche, Mareike, Rubnitz, Jeffrey E., Stary, Jan, Tierens, Anne, Tomizawa, Daisuke, Zwaan, C. Michel, Kaspers, Gertjan J.L.
Publicado 2023

Sugemalimab Monotherapy for Patients With Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma (GEMSTONE-201): Results From a Single-Arm, Multicenter, Phase II Study

por Huang, Huiqiang, Tao, Rong, Hao, Siguo, Yang, Yu, Cen, Hong, Zhou, Hui, Guo, Ye, Zou, Liqun, Cao, Junning, Huang, Yunhong, Jin, Jie, Zhang, Liling, Yang, Haiyan, Xing, Xiaojing, Zhang, Huilai, Liu, Yanyan, Ding, Kaiyang, Qi, Qinzhou, Zhu, Xiaoli, Zhu, Dan, Wang, Siyuan, Fang, Teng, Dai, Hangjun, Shi, Qingmei, Yang, Jason
Publicado 2023

Long Noncoding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia

por Farrar, Jason E., Smith, Jenny L., Othus, Megan, Huang, Benjamin J., Wang, Yi-Cheng, Ries, Rhonda, Hylkema, Tiffany, Pogosova-Agadjanyan, Era L., Challa, Sneha, Leonti, Amanda, Shaw, Timothy I., Triche, Timothy J., Gamis, Alan S., Aplenc, Richard, Kolb, E. Anders, Ma, Xiaotu, Stirewalt, Derek L., Alonzo, Todd A., Meshinchi, Soheil
Publicado 2023

Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study

por Paz-Ares, Luis, Champiat, Stephane, Lai, W. Victoria, Izumi, Hiroki, Govindan, Ramaswamy, Boyer, Michael, Hummel, Horst-Dieter, Borghaei, Hossein, Johnson, Melissa L., Steeghs, Neeltje, Blackhall, Fiona, Dowlati, Afshin, Reguart, Noemi, Yoshida, Tatsuya, He, Kai, Gadgeel, Shirish M., Felip, Enriqueta, Zhang, Yiran, Pati, Amrita, Minocha, Mukul, Mukherjee, Sujoy, Goldrick, Amanda, Nagorsen, Dirk, Hashemi Sadraei, Nooshin, Owonikoko, Taofeek K.
Publicado 2023

Coverage and Cost-of-Care Links: Addressing Financial Toxicity Among Patients With Hematologic Cancer and Their Caregivers

por Edward, Jean S., McLouth, Laurie E., Rayens, Mary Kay, Eisele, Lori P., Davis, Tani S., Hildebrandt, Gerhard
Publicado 2023

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

por Makker, Vicky, Colombo, Nicoletta, Herráez, Antonio Casado, Monk, Bradley J., Mackay, Helen, Santin, Alessandro D., Miller, David S., Moore, Richard G., Baron-Hay, Sally, Ray-Coquard, Isabelle, Ushijima, Kimio, Yonemori, Kan, Kim, Yong Man, Guerra Alia, Eva M., Sanli, Ulus A., Bird, Steven, Orlowski, Robert, McKenzie, Jodi, Okpara, Chinyere, Barresi, Gianmaria, Lorusso, Domenica
Publicado 2023

Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)

por Olofsson Bagge, Roger, Nelson, Axel, Shafazand, Amir, All-Eriksson, Charlotta, Cahlin, Christian, Elander, Nils, Helgadottir, Hildur, Kiilgaard, Jens Folke, Kinhult, Sara, Ljuslinder, Ingrid, Mattsson, Jan, Rizell, Magnus, Sternby Eilard, Malin, Ullenhag, Gustav J., Nilsson, Jonas A., Ny, Lars, Lindnér, Per
Publicado 2023

Camrelizumab Plus Apatinib in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma: An Open-Label, Single-Arm, Phase II Study

por Ding, Xi, Zhang, Wei-Jing, You, Rui, Zou, Xiong, Wang, Zhi-Qiang, Ouyang, Yan-Feng, Peng, Lan, Liu, You-Ping, Duan, Chong-Yang, Yang, Qi, Lin, Chao, Xie, Yu-Long, Chen, Si-Yuan, Liu, Yong-Long, Gu, Chen-Mei, Xie, Ruo-Qi, Huang, Pei-Yu, Hong, Ming-Huang, Hua, Yi-Jun, Chen, Ming-Yuan
Publicado 2023

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

por Muñoz, Andrés, Ay, Cihan, Grilz, Ella, López, Sonia, Font, Carme, Pachón, Vanesa, Castellón, Victoria, Martínez-Marín, Virginia, Salgado, Mercedes, Martínez, Eva, Calzas, Julia, Ortega, Laura, Rupérez, Ana, Salas, Eduardo, Pabinger, Ingrid, Soria, Jose Manuel
Publicado 2023

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

por Davies, Andrew J., Barrans, Sharon, Stanton, Louise, Caddy, Josh, Wilding, Sam, Saunders, Geoff, Mamot, Christoph, Novak, Urban, McMillan, Andrew, Fields, Paul, Collins, Graham P., Stephens, Richard, Cucco, Francesco, Sha, Chulin, van Hoppe, Moniek, Tooze, Reuben, Davies, John R., Griffiths, Gareth, Schuh, Anna, Burton, Catherine, Westhead, David R., Du, Ming-Qing, Johnson, Peter W.M.
Publicado 2023

Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial...

por Xia, Jieyun, Li, Hujun, Yan, Zhiling, Zhou, Dian, Wang, Ying, Qi, Yuekun, Cao, Jiang, Li, Depeng, Cheng, Hai, Sang, Wei, Zhu, Feng, Sun, Haiying, Chen, Wei, Qi, Kunming, Yan, Dongmei, Qiu, Tingting, Qiao, Jianlin, Yao, Ruosi, Liu, Yang, Wang, Xue, Zhang, Yanlei, Peng, Shuixiu, Huang, Chih-Hua, Zheng, Junnian, Li, Zhenyu, Chang, Alex H., Xu, Kailin
Publicado 2023